Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jose Diaz‑Chavez"'
Autor:
Alejandro Schcolnik-Cabrera, Alma Chavez-Blanco, Guadalupe Dominguez-Gomez, Mandy Juarez, Ariana Vargas-Castillo, Rafael Isaac Ponce-Toledo, Donna Lai, Sheng Hua, Armando R. Tovar, Nimbe Torres, Delia Perez-Montiel, Jose Diaz-Chavez, Alfonso Duenas-Gonzalez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract The malignant energetic demands are satisfied through glycolysis, glutaminolysis and de novo synthesis of fatty acids, while the host curses with a state of catabolism and systemic inflammation. The concurrent inhibition of both, tumor anabo
Externí odkaz:
https://doaj.org/article/f99339e0268a4075931c6a4545b04390
Autor:
Myrna Candelaria, Erick de la Cruz-Hernandez, Lucia Taja-Chayeb, Enrique Perez-Cardenas, Catalina Trejo-Becerril, Aurora Gonzalez-Fierro, Alma Chavez-Blanco, Ernesto Soto-Reyes, Guadalupe Dominguez, Jaenai E Trujillo, Jose Diaz-Chavez, Alfonso Duenas-Gonzalez
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e29181 (2012)
BACKGROUND: Down regulation of genes coding for nucleoside transporters and drug metabolism responsible for uptake and metabolic activation of the nucleoside gemcitabine is related with acquired tumor resistance against this agent. Hydralazine has be
Externí odkaz:
https://doaj.org/article/10635800c34a467b85da06632948f974
Autor:
Dennis Cerrato-Izaguirre, Jonathan González-Ruíz, José Diaz-Chavez, Andrea Ramírez, Anna Scavuzzo, Miguel A. Jimenez, Carlo Cortés-González, Jairo A. Rubio, María D. Pérez-Montiel, Claudia M. García-Cuellar, Luis A. Herrera, Yesennia Sánchez-Pérez, Felipe Vaca-Paniagua, Salim Barquet-Muñoz, David Cantu-de-Leon, Promita Bose, Diddier Prada
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Background Health disparities have been highlighted among patient with prostate adenocarcinoma (PRAD) due to ethnicity. Mexican men present a more aggressive disease than other patients resulting in less favorable treatment outcome. We aimed
Externí odkaz:
https://doaj.org/article/aa27e0284ff54b798950f20f0227eccc
Autor:
María D. Pérez-Montiel, Dennis Cerrato-Izaguirre, Yesennia Sánchez-Pérez, Jose Diaz-Chavez, Carlo César Cortés-González, Jairo A. Rubio, Miguel A. Jiménez-Ríos, Luis A. Herrera, Anna Scavuzzo, Abelardo Meneses-García, Ricardo Hernández-Martínez, Felipe Vaca-Paniagua, Andrea Ramírez, Alicia Orozco, David Cantú-de-León, Diddier Prada
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 2; Pages: 1092
Bladder cancer (BC) is the most common neoplasm of the urinary tract, which originates in the epithelium that covers the inner surface of the bladder. The molecular BC profile has led to the development of different classifications of non-muscle inva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500de5aff0da300066ac920f2ce4f295
https://doi.org/10.3390/ijms24021092
https://doi.org/10.3390/ijms24021092
Autor:
Donna Lai, Alfonso Dueñas González, Alejandro Schcolnik‑Cabrera, Guadalupe Dominguez‑Gomez, Sheng Hua, Armando R. Tovar, Mandy Juarez, Alma Chavez‑Blanco, Jose Diaz‑Chavez
Publikováno v:
Oncol Lett
Cancer upregulates glycolysis, glutaminolysis and lipogenesis, and induces a catabolic state in patients. The concurrent inhibition of both tumor anabolism and host catabolism, and the energetic consequences of such an approach, have not previously b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5340e175ba01f0e27890bc3c35a8807
https://pubmed.ncbi.nlm.nih.gov/32782623
https://pubmed.ncbi.nlm.nih.gov/32782623
Autor:
Marisol Ramírez‑Yautentzi, Alejandro Schcolnik‑Cabrera, Alma Chavez‑Blanco, Alfonso Dueñas González, Rocío Morales‑Bárcenas, Jose Diaz‑Chavez, Lucía Taja‑Chayeb, Guadalupe Dominguez‑Gomez
Publikováno v:
Oncology Letters
Lonidamine, 6-Diazo-5-oxo-L-norleucine (DON) and orlistat are well known inhibitors of glycolysis, glutaminolysis and of de novo fatty acid synthesis, respectively. Although their antitumor effects have been explored in detail, the potential inhibiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9cbffba868a8c00fd7fa341ca03eb7
https://doi.org/10.3892/ol.2019.11008
https://doi.org/10.3892/ol.2019.11008
Autor:
Guadalupe Dominguez‑Gomez, Alejandro Schcolnik‑Cabrera, Jose Diaz‑Chavez, Alfonso Dueñas González, Dominique Cortez‑Pedroza, Fredy Beltran‑Anaya, Aurora Gonzalez‑Fierro, Lucía Taja Chayeb, Alberto Cedro‑Tanda, Alfredo Hidalgo‑Miranda, Alma Chavez‑Blanco
Publikováno v:
Oncology reports. 42(3)
Ribavirin exhibits inhibitory effects on the epigenetic enzyme enhancer of zeste homolog 2 (EZH2), which participates in lymphomagenesis. Additionally, preclinical and clinical studies have demonstrated the anti‑lymphoma activity of this drug. To f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a38f03437b4f607078cb54bb04c509
https://pubmed.ncbi.nlm.nih.gov/31322273
https://pubmed.ncbi.nlm.nih.gov/31322273
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
One of the primary diseases that cause death worldwide is cancer. Cancer cells can be intrinsically resistant or acquire resistance to therapies and drugs used for cancer treatment through multiple mechanisms of action that favor cell survival and pr
Externí odkaz:
https://doaj.org/article/06e8fa0b0b3645578428d78efedfd953
Autor:
Diddier Prada, Cristian Arriaga-Canon, Jose Diaz-Chavez, Carlo Cortes, Marco Andonegui-Elguera, Pedro Perez-Collado, Rodolfo Muniz, David Cantu-de-Leon, Paula Cabrera-Galeana, Enrique Bargallo, Luis Herrera, Fernando Penaloza
Publikováno v:
Cancer Research. 79:5256-5256
Obesity has been widely associated with chronic diseases, including cancer. Obesity increases the risk of developing several types of cancer, both in women and men, especially breast cancer in postmenopausal women. However, the role of obesity after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4379b55676cc0153e7b66bb52614b9ba
https://doi.org/10.1158/1538-7445.am2019-5256
https://doi.org/10.1158/1538-7445.am2019-5256
Autor:
Orlando Vargas-Sierra, Jennifer Hernández-Juárez, Perla Yaceli Uc-Uc, Luis A Herrera, Guadalupe Domínguez-Gómez, Patricio Gariglio, José Díaz-Chávez
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 29, Iss 1, p 16 (2024)
Background: The SLC5A8 gene is silenced in various types of cancer, including cervical cancer; we recently demonstrated that the SLC5A8 gene is also silenced in cervical cancer by hypermethylation of the CpG island in the gene promoter. This study ai
Externí odkaz:
https://doaj.org/article/01955ed0c05d4868aae7ed032ceb0e08